An Evaluation of Chromogranin A Versus Gastrin and Progastrin in Gastrinoma Diagnosis and Control

References

• Mignon M , JaisP , CadiotG , YedderD , VatierJ. Clinical features and advances in biological diagnostic criteria for Zollinger–Ellison syndrome.Front. Gastrointest. Res.23 , 223 – 239 ( 1995 ).
   Google Scholar
• Rindi G , KlöppelG. Endocrine tumors of the gut and pancreas: Tumor biology and classification.Neuroendocrinology80 , 12 – 15 ( 2004 ).
   PubMedGoogle Scholar
• Jensen RT , NiederleB , MitryEet al. Gastrinoma (duodenal and pancreatic). Neuroendocrinology 84 , 173 – 182 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Yu F , VenzonDJ , SerranoJet al. Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger–Ellison syndrome. J. Clin. Oncol. 17 , 615 – 630 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Gibril F , JensenRT. Advances in evaluation and management of gastrinomas in patients with Zollinger–Ellison syndrome.Curr. Gastroenterol. Rep.7 , 114 – 121 ( 2005 ).
   PubMedGoogle Scholar
• Klöppel G , AnlaufM. Epidemiology, tumor biology and histopathological classification of neuroendocrine tumors of the gastrointestinal tract.Best Pract. Res. Clin. Gastroenterol.19 , 507 – 517 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Komminoth P , PerrenA , ÖbergK , RindiG , KlöppelG , HeitzPU. Gastrinoma . In: WHO Classification of Tumors . IARC Press , Lyon, France , 191 – 194 ( 2004 ).
   Google Scholar
• Murugesan SV , VarroA , PritchardDM. Strategies to determine whether hypergastrinemia is due to Zollinger–Ellison syndrome rather than a more common benign cause.Aliment. Pharmacol. Ther.29 , 1055 – 1068 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF . Gastrins in serum: a review of gastrin radioimmunoanalysis and the discovery of gastrin heterogeneity in serum.Scand. J. Gastroenterol.8 , 577 – 583 ( 1973 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF . The art of measuring gastrin in plasma: a dwindling diagnostic discipline?Scand. J. Clin. Lab. Invest.68 , 353 – 361 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , GingrasM-H , BardramL , HilstedL , GoetzeJP , PoitrasP. The Zollinger–Ellison syndrome and mismeasurement of gastrin.Gastroenterology140 , 1444 – 1453 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , BardramL , HilstedL , PoitrasP , GoetzeJP. Pitfalls in diagnostic gastrin measurements.Clin. Chem.58 , 831 – 836 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , StadilF. Gel filtration studies on immunoreactive gastrin in serum from Zollinger–Ellison patients.Gut14 , 369 – 373 ( 1973 ).
   PubMed Web of Science ®Google Scholar
• Bardram L . Progastrin in serum from Zollinger–Ellison patients. An indicator of malignancy?Gastroenterology98 , 1420 – 1426 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , BundgaardJB , GoetzeJP , Friis-HansenL , HilstedL , JohnsenAH. Naming progastrin-derived peptides.Regul. Peptides120 , 177 – 183 ( 2004 ).
   PubMedGoogle Scholar
• Stabile BE , HowardTJ , PassaroEJr , O’ConnorDT. Source of plasma chromogranin A elevation in gastrinoma patients.Arch. Surg.125 , 451 – 453 ( 1990 ).
   PubMedGoogle Scholar
• Syversen U , MignonM , BonfilsS , KristensenA , WaldumHL. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients.Acta Oncol.32 , 161 – 165 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Goebel SU , SerranoJ , YuF , GibrilF , VenzonDJ , JensenRT. Prospective study of the value of serum chromogranin A or serum gastrin levels in assessment of the presence, extent and growth of gastrinomas.Cancer85 , 1470 – 1483 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Abou-Saif A , GibrilF , OjeaburuJVet al. Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas. Cancer 98 , 249 – 261 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Taupenot L , HarperKL , O’ConnorDT. The chromogranin-secretogranin family.N. Engl. J. Med.348 , 1134 – 1149 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Helle KB . The granin family of uniquely acid proteins of the diffuse neuroendocrine system: comparative and functional aspects.Biol. Rev.79 , 769 – 794 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Helle KB . Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system.Results Problems Cell. Diff.50 , 21 – 44 ( 2010 ).
   PubMedGoogle Scholar
• Jensen TB , HilstedL , RehfeldJF. Library of sequence-specific radioimmunoassays for human chromogranin A.Clin. Chem.45 , 549 – 560 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Stridsberg M , ErikssonB , ÖbergK , JansonET. A panel of 11 region-specific radioimmunoassay for measurement of human chromogranin A.Regul. Pept.117 , 219 – 227 ( 2004 ).
   PubMedGoogle Scholar
• Rehfeld JF , StadilF , RubinB. Production and evaluation of antibodies for the radioimmunoassay of gastrin.Scand. J. Clin. Lab. Invest.30 , 221 – 232 ( 1972 ).
   PubMed Web of Science ®Google Scholar
• Stadil F , RehfeldJF. Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay.Scand. J. Gastroenterol.8 , 101 – 112 ( 1973 ).
   PubMed Web of Science ®Google Scholar
• Hilsted L , RehfeldJF. Measurement of precursors for α-amidated hormones by radioimmunoassay of glycine-extended peptides after trypsin-carboxypeptidase B cleavage.Analyt. Biochem.152 , 119 – 126 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Bardram L , RehfeldJF. Production and evaluation of monospecific antibodies for a processing-independent sequence of human progastrin.Scand. J. Clin. Lab. Invest.49 , 173 – 182 ( 1989 ).
   PubMed Web of Science ®Google Scholar
• Bardram L , RehfeldJF. Processing-independent radioimmunoanalysis: a general analytical principle applied to progastrin and its products.Analyt. Biochem.175 , 537 – 543 ( 1988 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , GoetzeJP. The posttranslational phase of gene expression: new possibilities in molecular diagnosis.Curr. Mol. Med.3 , 25 – 38 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Börglum T , RehfeldJF , DrivsholmL , HilstedL. Processing-independent quantitation of chromogranin A in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas.Clin. Chem.53 , 438 – 446 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , ZhuX , NorrbomCet al. Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and -17. Biochem. J. 415 , 35 – 43 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• J⊘rgensen NR , RehfeldJF , BardramL , HilstedL. Processing-independent analysis in the diagnosis of gastrinomas.Scand. J. Gastroenterol.33 , 379 – 385 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , FederspielB , BardramL. A neuroendocrine tumor syndrome from cholecystokinin secretion.N. Engl. J. Med.368 , 1165 – 1166 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jensen KH , HilstedL , JensenC , MynsterT , RehfeldJF , KniggeU. Chromogranin A is a sensitive marker of growth or regression of ileocecal neuroendocrine tumors.Scand. J. Gastroenterol.48 , 70 – 77 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cetin Y , BargstenG , GrubeD. Mutual relationships between chromogranins A and B and gastrin in individual gastrin cells.Proc. Natl Acad. Sci. USA89 , 2912 – 2916 ( 1992 ).
   PubMed Web of Science ®Google Scholar